← Back to headlines
J&J Pauses Enrollment in Mid-Stage Alzheimer's Drug Trial
AC Immune announced that its partner Johnson & Johnson has paused enrollment in a mid-stage clinical trial for an Alzheimer’s drug.
18 Feb, 11:58 — 18 Feb, 11:58
ℹOnly 1 source covers this story
